StockData
Amneal Pharmaceuticals, Inc. logo

Amneal Pharmaceuticals, Inc. (AMRX) stock

AMRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/3062% above fair value
$21.23−0.15 (-0.70%)

Close on Nov 16, 2026Market cap $6.78BP/E 43.3Yield –

Amneal Pharmaceuticals total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Amneal Pharmaceuticals's total debt was $2.57B at Jun 30, 2026. For fiscal 2025 it was $2.57B, up 7.8% from the year before. The highest annual figure on record is $2.78B in fiscal 2020.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.57B+7.8%
FY2024Dec 31, 2024$2.39B-1.4%
FY2023Dec 31, 2023$2.42B-7.7%
FY2022Dec 31, 2022$2.62B-3.3%
FY2021Dec 31, 2021$2.71B-2.5%
FY2020Dec 31, 2020$2.78B+5.7%
FY2019Dec 31, 2019$2.63B-0.8%
FY2018Dec 31, 2018$2.65B+83.6%
FY2017Dec 31, 2017$1.44B–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$2.57B+18.0%
Q1 FY2026Mar 31, 2026$2.57B+17.7%
Q4 FY2025Dec 31, 2025$2.57B+7.8%
Q3 FY2025Sep 30, 2025$2.57B+7.5%
Q2 FY2025Jun 30, 2025$2.18B-9.4%
Q1 FY2025Mar 31, 2025$2.19B-9.4%
Q4 FY2024Dec 31, 2024$2.39B-1.4%
Q3 FY2024Sep 30, 2024$2.39B-6.9%
Q2 FY2024Jun 30, 2024$2.40B-6.9%
Q1 FY2024Mar 31, 2024$2.41B-7.0%
Q4 FY2023Dec 31, 2023$2.42B-7.7%
Q3 FY2023Sep 30, 2023$2.57B-2.5%
Q2 FY2023Jun 30, 2023$2.58B-2.7%
Q1 FY2023Mar 31, 2023$2.59B-4.1%
Q4 FY2022Dec 31, 2022$2.62B-3.3%
Q3 FY2022Sep 30, 2022$2.64B-3.0%
Q2 FY2022Jun 30, 2022$2.65B-3.6%
Q1 FY2022Mar 31, 2022$2.70B-2.0%
Q4 FY2021Dec 31, 2021$2.71B-2.5%
Q3 FY2021Sep 30, 2021$2.72B-2.5%
Q2 FY2021Jun 30, 2021$2.75B-1.6%
Q1 FY2021Mar 31, 2021$2.76B-1.6%
Q4 FY2020Dec 31, 2020$2.78B+5.7%
Q3 FY2020Sep 30, 2020$2.79B+5.7%
Q2 FY2020Jun 30, 2020$2.79B+5.8%
Q1 FY2020Mar 31, 2020$2.80B+5.9%
Q4 FY2019Dec 31, 2019$2.63B-0.8%
Q3 FY2019Sep 30, 2019$2.64B-5.8%
Q2 FY2019Jun 30, 2019$2.64B-0.0%
Q1 FY2019Mar 31, 2019$2.65B+83.2%
Q4 FY2018Dec 31, 2018$2.65B–
Q3 FY2018Sep 30, 2018$2.80B–
Q2 FY2018Jun 30, 2018$2.64B–
Q4 FY2017Dec 31, 2017$1.44B–

More Amneal Pharmaceuticals figures

See a number that looks wrong?